VC
Vivo Capital Portfolio holdings
AUM
$977M
1-Year Return
209.68%
This Quarter Return
+46.63%
1 Year Return
+209.68%
3 Year Return
+1,480.07%
5 Year Return
+2,591.98%
10 Year Return
–
AUM
$1B
AUM Growth
+$220M
(+28%)
Cap. Flow
-$15.9M
Cap. Flow
% of AUM
-1.59%
Top 10 Holdings %
Top 10 Hldgs %
62.05%
Holding
51
New
6
Increased
3
Reduced
11
Closed
2
Top Buys
| 1 |
Insmed
INSM
|
+$34M |
| 2 |
CBAY
Cymabay Therapeutics
CBAY
|
+$15.3M |
| 3 |
uniQure
QURE
|
+$10.8M |
| 4 |
Kiniksa Pharmaceuticals
KNSA
|
+$10.4M |
| 5 |
DERM
Dermira, Inc.
DERM
|
+$9.49M |
Top Sells
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$67.3M |
| 2 |
Ascendis Pharma
ASND
|
+$14.1M |
| 3 |
Apellis Pharmaceuticals
APLS
|
+$9.58M |
| 4 |
Crinetics Pharmaceuticals
CRNX
|
+$9.49M |
| 5 |
ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
|
+$5.91M |
Sector Composition
| 1 | Healthcare | 97.66% |
| 2 | Materials | 1.16% |